24/ 2. 167 patienter (1, 11%) for lumiracoxib mod 23/ 2. 159 patienter (1, 07%) for NSAID, med et RF på 1, 04 [95% KI 0, 59- 1, 84] p=0, 8918.
lumiracoxib versus 23/ 2159 patients (1.07%) for NSAIDs, with a hazard ratio (HR) of 1.04 [95% CI 0.59-1.84] p=0.8918.